These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2104234)

  • 1. Characterization of a T-cell-derived mast cell costimulatory activity (MCA) that acts synergistically with interleukin 3 and interleukin 4 on the growth of murine mast cells.
    Schmitt E; Hüls C; Nagel B; Rüde E
    Cytokine; 1990 Nov; 2(6):407-15. PubMed ID: 2104234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of differential effects of cytokines on mast cells derived from murine bone marrow and peripheral blood mononuclear cells.
    Rottem M; Hull G; Metcalfe DD
    Exp Hematol; 1994 Nov; 22(12):1147-55. PubMed ID: 7523167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a T cell-derived lymphokine that acts synergistically with IL 3 on the growth of murine mast cells and is identical with IL 4.
    Schmitt E; Fassbender B; Beyreuther K; Spaeth E; Schwarzkopf R; Rüde E
    Immunobiology; 1987 Aug; 174(4-5):406-19. PubMed ID: 3500117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3.
    Smith CA; Rennick DM
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1857-61. PubMed ID: 2937061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 (IL-4) in combination with IL-11 or IL-6 reverses the inhibitory effect of IL-3 on early B lymphocyte development.
    Neben S; Donaldson D; Fitz L; Calvetti J; Neben T; Turner K; Hirayama F; Ogawa M
    Exp Hematol; 1996 Jun; 24(7):783-9. PubMed ID: 8647228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth regulation of multi-factor-dependent myeloid cell lines: IL-4, TGF-beta and pertussis toxin modulate IL-3- or GM-CSF-induced growth by controlling cell cycle length.
    Koyasu S; Miyajima A; Arai K; Okajima F; Ui M; Yahara I
    Cell Struct Funct; 1989 Aug; 14(4):459-71. PubMed ID: 2680112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interleukin-4 on the growth of granulocyte-macrophage progenitor cells stimulated by hematopoietic growth factors.
    Sato T; Misago M; Tsukada J; Kikuchi M; Oda S; Chiba S; Eto S
    J UOEH; 1990 Jun; 12(2):163-74. PubMed ID: 1697091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progenitor cells in murine bone marrow stimulated by growth factors produced by the AF1-19T rat cell line.
    Kriegler AB; Bradley TR; Bertoncello I; Hamilton JA; Hart PH; Piccoli DS; Hodgson GS
    Exp Hematol; 1990 Jun; 18(5):372-8. PubMed ID: 2186922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic action of interleukin-10 (IL-10) with IL-3, IL-4 and stem cell factor on colony formation from murine mast cells in culture.
    Tsuji K; Koike K; Komiyama A; Miyajima A; Arai K; Nakahata T
    Int J Hematol; 1995 Feb; 61(2):51-60. PubMed ID: 7537549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines.
    Budel LM; Delwel R; van Buitenen C; Hoogerbrugge H; Löwenberg B
    Leukemia; 1993 Mar; 7(3):426-34. PubMed ID: 7680401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 4 as an essential factor for in vitro clonal growth of murine connective tissue-type mast cells.
    Hamaguchi Y; Kanakura Y; Fujita J; Takeda S; Nakano T; Tarui S; Honjo T; Kitamura Y
    J Exp Med; 1987 Jan; 165(1):268-73. PubMed ID: 3491870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
    Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
    Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth response of Lin-Thy-1+ hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors.
    Jacobsen SE; Ruscetti FW; Ortiz M; Gooya JM; Keller JR
    Exp Hematol; 1994 Sep; 22(10):985-9. PubMed ID: 7522186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cofactors are essential for stem cell factor-dependent growth and maturation of mast cell progenitors: comparative effects of interleukin-3 (IL-3), IL-4, IL-10, and fibroblasts.
    Rennick D; Hunte B; Holland G; Thompson-Snipes L
    Blood; 1995 Jan; 85(1):57-65. PubMed ID: 7528573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells.
    Matsuda H; Kannan Y; Ushio H; Kiso Y; Kanemoto T; Suzuki H; Kitamura Y
    J Exp Med; 1991 Jul; 174(1):7-14. PubMed ID: 1711569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4.
    Hültner L; Moeller J; Schmitt E; Jäger G; Reisbach G; Ring J; Dörmer P
    J Immunol; 1989 May; 142(10):3440-6. PubMed ID: 2785556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation of soluble antigens by mast cells: upregulation by interleukin-4 and granulocyte/macrophage colony-stimulating factor and downregulation by interferon-gamma.
    Frandji P; Tkaczyk C; Oskéritzian C; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
    Cell Immunol; 1995 Jun; 163(1):37-46. PubMed ID: 7758129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.